The contractor shall: (1) perform and document a quality evaluation of the study product to certify that IT meets the regulatory requirements for use in studies by ensuring that the manufacturing…
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $263,619
Award facts
- Contract value 23% obligated
-
- $263,619.13 Current, with exercised options
- $1,151,180.13 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$242,542 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $506,161 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for $1,151,180.13. The contract is a delivery order under a larger HIV Microbicides and Biomedical Prevention program that runs from 2016-2021.
Under this contract, ABL will perform quality evaluation and certification of a study product to ensure it meets regulatory requirements for use in studies. This includes ensuring the manufacturing processes are well-documented and the resulting data is adequate. The contract has a period of performance ending on July 14, 2022 and was awarded on May 1, 2020. There is no set-aside designation for this contract.
ABL is a for-profit organization and manufacturer of goods that specializes in the development of biologics, vaccines, and immunotherapies. The company has extensive experience supporting federal agencies like NIH and HHS on infectious disease research and medical countermeasure development programs.
Description
The contractor shall: (1) perform and document a quality evaluation of the study product to certify that IT meets the regulatory requirements for use in studies by ensuring that the manufacturing processes are well-documented, and the resulting data
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $263,619 on 75N93020F00001. Its potential value, with all options, is $1,151,180.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award